- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
GoTo gets $1.3bn in pre-IPO funding
Google and Tencent returned to reinvest in e-commerce and on-demand services group GoTo as it prepares to go public at a valuation of up to $30bn.
Nov 11, 2021Daily deal net: November 11, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Nov 11, 2021Nykaa nabs $721m in initial public offering
The Max Group and TVS-backed fashion and beauty marketplace operator has listed on the BSE and NSE and has achieved a market cap of $13.5bn.
Nov 11, 2021Braze aims for $402m in its IPO
The Citi-backed customer engagement platform developer has set terms for an initial public offering which could top $400m.
Nov 11, 2021Alcon advances to $475m Ivantis acquisition
Novartis eyecare subsidiary Alcon has agreed to acquire the Institut Mérieux, Ascension Health and MemorialCare Health System-backed MIGS technology provider.
Nov 11, 2021Entrada Therapeutics enters Nasdaq
The Ohio State spinout has gone public in an upsized IPO sized at approximately $182m.
Nov 11, 2021Neo4j's series F graph reaches $390m
The Alphabet and DTCP-backed graph software provider added $65m to its latest round, hiking its overall funding to about $580m.
Nov 11, 2021Autobrains authorises $101m series C round
BMW, Continental, Knorr-Bremse and VinFast backed the autonomous perception technology developer, which traces its roots to Technion.
Nov 11, 2021Workato flows in $200m in funding
The Salesforce, Workday and ServiceNow-backed software integration provider raised the sries E financing at a $5.7bn valuation.
Nov 11, 2021Alchemy manifests $250m in funding
The Stanford-backed blockchain development platform increased its valuation to $3.5bn in the series C round.
Nov 11, 2021Arbor Bio harbours $215m
Vertex Pharmaceuticals and Illumina Ventures both contributed to a round that increased the genetic therapeutics developer's total funding to over $300m.
Nov 11, 2021Egle Therapeutics lands series A funding
Takeda Ventures was among the participants in a $46.5m round closed nearly a year after its parent company launched a partnership with the Institut Curie spinout.
Nov 11, 2021Featured Content
GCV Powerlist 2026Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.GCV Powerlist 2026
Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


